James L. Levin

710 total citations
9 papers, 557 citations indexed

About

James L. Levin is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James L. Levin has authored 9 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James L. Levin's work include Xenotransplantation and immune response (3 papers), Organ Transplantation Techniques and Outcomes (2 papers) and Respiratory Support and Mechanisms (2 papers). James L. Levin is often cited by papers focused on Xenotransplantation and immune response (3 papers), Organ Transplantation Techniques and Outcomes (2 papers) and Respiratory Support and Mechanisms (2 papers). James L. Levin collaborates with scholars based in United States and United Kingdom. James L. Levin's co-authors include Scott K. Pruitt, Fred Sanfilippo, Henry C. Marsh, Bradley H. Collins, Alfred R. Rudolph, R. Randal Bollinger, Angela Vincent, Sara J. Piddlesden, B. Paul Morgan and James R. Mault and has published in prestigious journals such as Journal of Biological Chemistry, Critical Care Medicine and Transplantation.

In The Last Decade

James L. Levin

9 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James L. Levin United States	8	303	188	135	63	62	9	557
Chantale Lacelle United States	11	164 0.5×	279 1.5×	74 0.5×	19 0.3×	15 0.2×	21	697
Jean-Paul Soulillou France	12	134 0.4×	363 1.9×	87 0.6×	32 0.5×	11 0.2×	14	638
Fatma Aytül Uyar Türkiye	13	48 0.2×	221 1.2×	76 0.6×	15 0.2×	19 0.3×	19	432
Oktavijan P. Minanov United States	13	379 1.3×	108 0.6×	108 0.8×	15 0.2×	12 0.2×	18	620
Françoise Rossi France	5	45 0.1×	193 1.0×	34 0.3×	132 2.1×	49 0.8×	9	402
Reyna S. Goodman United Kingdom	10	97 0.3×	150 0.8×	18 0.1×	18 0.3×	43 0.7×	12	360
I Khalil France	13	317 1.0×	375 2.0×	520 3.9×	30 0.5×	46 0.7×	27	817
John Marker United States	6	241 0.8×	858 4.6×	597 4.4×	16 0.3×	28 0.5×	7	1.2k
Emily M. L. Chastain United States	6	25 0.1×	274 1.5×	55 0.4×	64 1.0×	50 0.8×	6	608
Sarah Peacock United Kingdom	9	158 0.5×	157 0.8×	30 0.2×	24 0.4×	7 0.1×	14	602

Countries citing papers authored by James L. Levin

Since Specialization

Citations

This map shows the geographic impact of James L. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Levin more than expected).

Fields of papers citing papers by James L. Levin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Levin. The network helps show where James L. Levin may publish in the future.

Co-authorship network of co-authors of James L. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Levin. A scholar is included among the top collaborators of James L. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Levin. James L. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Zimmerman, Janice L., R. Phillip Dellinger, Richard Straube, & James L. Levin. (2000). Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome. Critical Care Medicine. 28(9). 3149–3154. 61 indexed citations

Rittershaus, Charles W., Lawrence J. Thomas, David P. Miller, et al.. (1999). Recombinant Glycoproteins That Inhibit Complement Activation and Also Bind the Selectin Adhesion Molecules. Journal of Biological Chemistry. 274(16). 11237–11244. 43 indexed citations

Nomura, Nakao, Henry W. Lim, James L. Levin, & Shigeru Sassa. (1998). Effect of soluble complement receptor type 1 on porphyrin-induced phototoxicity in guinea pigs. Journal of Photochemistry and Photobiology B Biology. 42(1). 28–31. 2 indexed citations

Pruitt, Scott K., R. Randal Bollinger, Bradley H. Collins, et al.. (1997). EFFECT OF CONTINUOUS COMPLEMENT INHIBITION USING SOLUBLE COMPLEMENT RECEPTOR TYPE 1 ON SURVIVAL OF PIG-TO-PRIMATE CARDIAC XENOGRAFTS1. Transplantation. 63(6). 900–902. 69 indexed citations

Olmsted‐Davis, Elizabeth A., Scott K. Pruitt, Peter S. Greene, et al.. (1996). INHIBITION OF COMPLEMENT, EVOKED ANTIBODY, AND CELLULAR RESPONSE PREVENTS REJECTION OF PIG-TO-PRIMATE CARDIAC XENOGRAFTS1. Transplantation. 62(7). 1018–1023. 63 indexed citations

Piddlesden, Sara J., et al.. (1996). Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis. Journal of Neuroimmunology. 71(1-2). 173–177. 95 indexed citations

Pruitt, Scott K., Allan D. Kirk, R. Randal Bollinger, et al.. (1994). THE EFFECT OF SOLUBLE COMPLEMENT RECEPTOR TYPE 1 ON HYPERACUTE REJECTION OF PORCINE XENOGRAFTS. Transplantation. 57(3). 363–370. 199 indexed citations

Shah, Sudhir, John M. Lambert, Victor S. Goldmacher, et al.. (1993). Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusion. International Journal of Immunopharmacology. 15(6). 723–736. 10 indexed citations

Spannhake, Ernst Wm., James L. Levin, Albert L. Hyman, & Philip J. Kadowitz. (1981). 6-Keto-PGE1 exhibits more potent bronchodilatory activity in the cat than its precursor, PGI2. Prostaglandins. 21(2). 267–275. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact